Shares of BiVictriX Therapeutics Plc (LON:BVX – Get Free Report) traded up 17.6% during mid-day trading on Friday . The company traded as high as GBX 10 ($0.13) and last traded at GBX 10 ($0.13). 1,538,020 shares changed hands during trading, an increase of 1,320% from the average session volume of 108,326 shares. The stock had previously closed at GBX 8.50 ($0.11).
BiVictriX Therapeutics Stock Performance
The company has a market cap of £8.25 million, a P/E ratio of -250.00 and a beta of -0.73. The company has a quick ratio of 7.49, a current ratio of 4.40 and a debt-to-equity ratio of 8.81. The company has a 50 day moving average price of GBX 10 and a 200-day moving average price of GBX 10.76.
About BiVictriX Therapeutics
BiVictriX Therapeutics Plc, a biotechnology company, engages in the development of cancer therapies in the United Kingdom. The company develops Bi-Cygni therapeutics, which are selective for cancer types. Its lead program is BVX001, focuses on acute myeloid leukaemia, as well as develops BVX002 and BVX003 for various blood cancers and solid tumours.
Recommended Stories
- Five stocks we like better than BiVictriX Therapeutics
- Insider Trading – What You Need to Know
- Trinity Capital CEO on Leading Private Credit’s High-Yield Growth
- What is a Death Cross in Stocks?
- Lululemon Surges On Q3 Report: Analysts Step in To Support Market
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 10 Safe Investments with High Returns
Receive News & Ratings for BiVictriX Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiVictriX Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
